Trademark Overview
On Wednesday, September 24, 2025, a trademark application was filed for IMMUNEGPT with the United States Patent and Trademark Office. The USPTO has given the IMMUNEGPT trademark a serial number of 99410386. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, September 24, 2025. This trademark is owned by Omniscope Limited. The IMMUNEGPT trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable and recorded software for the analysis and processing of biological data; software incorporating machine learning algorithms trained on immune system data, including but not limited to T cell receptors (TCRs), B cell receptors (BCRs), and related immunological sequences; computer software leveraging artificial intelligence, specifically a transformer-based architecture, for the prediction and generation of immune cell receptor sequences; programs for processing paired and unpaired immune cell receptor data for research and educational purposes; applications for decoding and synthesizing sequence patterns using proprietary tokenization and context-specific learning algorithms.
Providing medical and clinical analysis services through software for immune cell receptor research; offering online non-downloadable AI-powered software for the evaluation and interpretation of T cell receptor (TCR) and B cell receptor (BCR)sequences to support medical diagnostics and immunological studies; enabling advanced predictive modelling for medical research and development related to immune system behaviour; consulting services for clinical applications involving bioinformatics and immune cell sequencing data; supporting healthcare and therapeutic research by offering tools for understanding immune interactionsthrough data-driven analysis.
Scientific and technical research into amino acid sequencing/sequences; Providing online, non-downloadable software for advanced bioinformatics research; cloudbased platforms for modelling, analyzing, and generating immune system receptor sequences using AI-driven methodologies; software as a service (SaaS) and machine learning as a service (MLaaS) featuring artificial intelligence for biological sequence analysis tailored to immune cells, including but not limited to T cell receptors (TCRs)and B cell receptors (BCRs); data hosting services supporting immune cell sequencing datasets for educational and professional research; developing specialized software frameworks that employ causal masking and custom loss functions for immune receptor study; scientific consultation services relating to the use of AI in immunology and molecular biology research.
